Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Stimulation of brain hormone action may improve pneumonia survival

31.01.2012
An international research team may have found a way to block a second wave of death that can result from pneumonia treatment.

Antibiotics are effective at killing pneumococcus – the cause of about 50 percent of pneumonias – but as it dies the bacterium releases potentially lethal toxins.

Adding an agonist that mimics the action of growth hormone-releasing hormone – which ultimately enables growth – may stop that second wave, according to research published in the Proceedings of the National Academy of Sciences.

"You have to take antibiotics, if you don't, the bugs will grow and you most likely will die anyway," said Dr. Rudolf Lucas, vascular biologist at the Medical College of Georgia at Georgia Health Sciences University.

Problems start when a bacterium that causes pneumonia, in this case pneumococcus, is inhaled. Symptoms include mucus buildup, cough, fever, chills and shortness of breath. Antibiotics are the front line treatment to kill the infection.

An unfortunate result of bacterium death is release of pneumolysin, a toxin that can trigger formation of holes in the walls of the millions of tiny air sacs and blood vessels in the lungs. The result is that fluid, blood and other products find their way into air sacs that were intended for oxygen exchange.

"It's like making a hole in a bucket," said Lucas. He and Dr. Andrew V. Schally, Distinguished Leonard M. Miller Professor of Pathology & Professor of Hematology/Oncology at the University of Miami Miller School of Medicine, are co-corresponding authors on the study.

Pneumolysin naturally binds to cholesterol, a component of all cell membranes including cells lining the air sacs, or alveoli. Once attached to the membrane, the toxin produces complexes that make holes in the membranes of the air sacs before escaping to do similar damage to nearby capillaries. While the close proximity of capillaries normally enables air sacs to replenish blood with oxygen and to remove carbon dioxide, the now open exchange enables fluid and cells from the capillaries to penetrate air sacs as well as the space in between them. To make matters worse, the toxin also blocks a protective sodium uptake system in the lungs that can help remove fluids. Within a few days, the patient is back in jeopardy. "These patients are being treated with an antibiotic and aggressive intensive care support and they (can) still die," Lucas said.

Schally, a Nobel Prize recipient for his discovery of hypothalamic hormones and Head of The Endocrine, Polypeptide and Cancer Institute, Veterans Affairs Medical Center in Miami, developed the agonist that may one day make the difference for these patients. The agonist was previously shown to help protect heart muscle in the aftermath of a heart attack.

Surprisingly, GHSU scientists detected receptors for growth hormone releasing hormone in cells lining the air sacs. Typically, growth hormone-releasing hormone is produced by the hypothalamus then goes to the pituitary which makes and releases growth hormone. "We were asking ourselves, what is it doing there?" Lucas said.

They got a clue when they applied the agonist to the growth hormone-releasing hormone in an animal model of pneumonia as well as human lung cells in culture: leaking was significantly reduced and beneficial sodium uptake was restored. Conversely, when they applied a hormone antagonist – to block its action – lung cells became leaky even without toxin exposure, further indicating the hormone's apparent role in protecting the lining of the air sacs and capillaries.

"This is an acute problem; dangerous lung fluid accumulation occurs within days in patients," said Lucas who anticipates the agonist, or a compound with a similar function, could someday be given to patients in those first few critical days to avoid the second onslaught.

As a result of the findings, extensive collaborative studies are being planned on the use of growth hormone-releasing hormone agonists to prevent edema in patients with bacterial pneumonia. Next steps include pursing a National Institutes of Health grant with Dr. Michael A. Matthay, Senior Associate, Cardiovascular Research Institute, University of California, San Francisco, to support more studies that include an isolated human lung model and a preclinical model of laboratory animals who follow the same course as patients: they are infected with the bacterium then given an antibiotic. In the model for the PNAS study, scientists gave the resulting toxin directly.

Dr. Trinad Chakraborty, Dean of the Faculty of Medicine at the University of Giessen in Germany, developed the purified toxin used for the study. Study co-authors Dr. Richard White, GHSU pharmacologist, showed restoration of sodium uptake, and Dr. Supriya Sridhar, GHSU research associate, performed the cell permeability experiments. University of Miami co-authors included Dr. Norman L. Block, Professor of Pathology, Urology, Oncology and Biomedical Engineering, as well as Dr. Ferenc G. Rick, Assistant Research Professor of Pathology.

Toni Baker | EurekAlert!
Further information:
http://www.georgiahealth.edu

More articles from Health and Medicine:

nachricht Researchers release the brakes on the immune system
18.10.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Norovirus evades immune system by hiding out in rare gut cells
12.10.2017 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Electrode materials from the microwave oven

19.10.2017 | Materials Sciences

New material for digital memories of the future

19.10.2017 | Materials Sciences

Physics boosts artificial intelligence methods

19.10.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>